TB-500
Learn why TB-500 product identity matters, what repair research can show, and how to evaluate recovery claims.
Have questions? Start with a free consultation.
No deposit. Our Gilbert team will contact you within one business day.
Understand the topic before choosing a treatment
TB-500 appears in discussions about wound healing and recovery, but the name is used inconsistently. Understanding exactly which substance a study tested is essential before applying its results to a product.
If your goal is to return to activity, describe what still limits you: pain, strength, range of motion or endurance. These are more useful consultation starting points than a stack name.
This is an educational guide. It does not establish product availability or that this option is suitable for you.
How it works—and what that tells us
Thymosin beta-4 participates in cell movement and repair biology. The shorter fragment commonly called TB-500 is not automatically equivalent to the full-length protein. Research on one cannot establish the effects of the other.
A mechanism explains how something may act.
Clinical studies test benefits and harms in specific people.
Your goals and health history shape the next step.
What the evidence shows
Preclinical and regulatory evidence review
FDA evaluated TB-500-related substances for a nominated wound-healing use and identified important identity and evidence gaps. Its review does not establish benefit for a marketed recovery injection.
What it does not establish
- Different salts, fragments and formulations should not be treated as interchangeable.
- Neither a plausible repair mechanism nor a testimonial establishes the effectiveness of a TB-500 recovery program.
Safety questions worth discussing
- Uncertain composition makes both quality assessment and risk assessment harder.
- Persistent weakness, swelling or loss of function warrants clinical evaluation before considering experimental products.
Bring your goals to the conversation
You can start with what you want to understand or improve. A consultation can help you assess the research and discuss other approaches; it does not commit you to a particular treatment.
- Do I need an examination, imaging or rehabilitation assessment?
- Was the evidence collected using the exact substance under discussion?
- How will improvement in function be measured?
Common questions about TB-500
Is TB-500 the same as thymosin beta-4?
Not necessarily. The names are often blurred in marketing. The FDA review distinguishes TB-500-related fragments and warns about inconsistent product naming.
Does combining it with BPC-157 prove better recovery?
No. Evidence for a combination must address the actual combination, including its safety. Two proposed mechanisms do not establish an added benefit.
What should I bring to a recovery consultation?
A description of the injury, what activities you cannot do comfortably, and any existing diagnosis, treatment or imaging information.
Sources and further reading
- FDA compounding advisory briefing: TB-500-related substances
U.S. Food and Drug Administration · 2026
The cited sources describe particular products, study populations or research questions. They are not endorsements of a LifeSpann treatment. Meet our team.
Start with your goals. The consultation is free.
Free consultation · No deposit
Talk through what you want to achieve, the evidence, and the options worth considering. You do not need to choose a peptide or commit to treatment.
Our front desk will contact you within one business day to answer questions and schedule your consultation.
Prefer to call? (480) 351-7151